SE9301290D0 - Anvaendning av en somatostatinanalog - Google Patents

Anvaendning av en somatostatinanalog

Info

Publication number
SE9301290D0
SE9301290D0 SE19939301290A SE9301290A SE9301290D0 SE 9301290 D0 SE9301290 D0 SE 9301290D0 SE 19939301290 A SE19939301290 A SE 19939301290A SE 9301290 A SE9301290 A SE 9301290A SE 9301290 D0 SE9301290 D0 SE 9301290D0
Authority
SE
Sweden
Prior art keywords
somatostatin analogue
pharmaceutical composition
somatostatin
analogue
administered
Prior art date
Application number
SE19939301290A
Other languages
English (en)
Other versions
SE9301290A0 (sv
Inventor
*Cavanak Thomas
*Harris Allan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878716324A external-priority patent/GB8716324D0/en
Priority claimed from GB878716326A external-priority patent/GB8716326D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE9301290A0 publication Critical patent/SE9301290A0/sv
Publication of SE9301290D0 publication Critical patent/SE9301290D0/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/16Somatostatin; related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SE19939301290A 1987-07-10 1993-04-20 Anvaendning av en somatostatinanalog SE9301290D0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878716324A GB8716324D0 (en) 1987-07-10 1987-07-10 Organic compounds
GB878716326A GB8716326D0 (en) 1987-07-10 1987-07-10 Organic compounds

Publications (2)

Publication Number Publication Date
SE9301290A0 SE9301290A0 (sv) 1993-04-20
SE9301290D0 true SE9301290D0 (sv) 1993-04-20

Family

ID=26292476

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8802569A SE503191C2 (sv) 1987-07-10 1988-07-08 Farmaceutisk komposition innehållande en somatostatinanalog samt användning därav
SE19939301290A SE9301290D0 (sv) 1987-07-10 1993-04-20 Anvaendning av en somatostatinanalog

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8802569A SE503191C2 (sv) 1987-07-10 1988-07-08 Farmaceutisk komposition innehållande en somatostatinanalog samt användning därav

Country Status (27)

Country Link
US (2) US5753618A (sv)
JP (1) JP2578477B2 (sv)
AU (1) AU618270B2 (sv)
BE (1) BE1001079A4 (sv)
CA (1) CA1328402C (sv)
CH (1) CH677449A5 (sv)
CS (1) CS411591A3 (sv)
CY (2) CY1631A (sv)
DE (2) DE3845000C2 (sv)
DK (2) DK174125B1 (sv)
ES (1) ES2010561A6 (sv)
FI (1) FI93308C (sv)
FR (1) FR2617714B1 (sv)
GB (1) GB2208200B (sv)
GR (1) GR1000172B (sv)
HK (1) HK16492A (sv)
HU (1) HU203480B (sv)
IE (1) IE61908B1 (sv)
IL (1) IL87044A0 (sv)
LU (1) LU87268A1 (sv)
MY (2) MY109309A (sv)
NL (1) NL194823C (sv)
NO (1) NO179359C (sv)
NZ (1) NZ225340A (sv)
PT (1) PT87957B (sv)
SE (2) SE503191C2 (sv)
SG (1) SG3692G (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5626945A (en) * 1993-09-28 1997-05-06 International Paper Company Repulpable, water repellant paperboard
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
WO1998008528A1 (en) 1996-08-30 1998-03-05 Biomeasure Incorporated Method of inhibiting fibrosis with a somatostatin agonist
ES2167189B1 (es) * 1999-12-17 2003-04-01 Lipotec Sa Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
EP2062914B1 (en) * 2001-06-08 2014-05-07 Ipsen Pharma Somatostatin-dopamine chimeric analogs
TWI287986B (en) * 2001-12-13 2007-10-11 Novartis Ag Use of Epothilones for the treatment of the carcinoid syndrome
US20030207811A1 (en) * 2002-05-03 2003-11-06 Schrier Bruce K. Method of treating retinopathy of prematurity using somatostatin analogs
SI1787658T1 (sl) 2005-11-10 2012-07-31 Chemi Spa Formulacije z trajnim sproščanjem somatostatin analognih inhibitorjev rastnega hormona
JP2009532346A (ja) * 2006-03-31 2009-09-10 イラスマス・ユニバーシティ・メディカル・センター・ロッテルダム 腫瘍増殖制御のための新規組成物
US20100160275A1 (en) * 2006-09-26 2010-06-24 Lee Eva Y H P Methods and compositions for cancer prevention and treatment
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US20090325863A1 (en) * 2008-06-13 2009-12-31 Kleinberg David L Somatostatin analogs and IGF-I inhibition for breast cancer prevention
GB201016436D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Method of making solid beads
GB201016433D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Apparatus and method for making solid beads
WO2012074559A2 (en) * 2010-12-02 2012-06-07 New York University Treatment of non-proliferative cystic disease
RU2652605C2 (ru) * 2011-06-02 2018-04-27 Зе Реджентс Оф Зе Юниверсити Оф Калифорния Блокада воспалительных протеаз тета-дефензинами
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素-多巴胺嵌合體類似物
WO2014070965A2 (en) 2012-11-01 2014-05-08 Ipsen Pharma S.A.S Somatostatin analogs and dimers thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621770A5 (en) * 1976-02-23 1981-02-27 Sandoz Ag Process for the preparation of novel peptide compounds
IE47421B1 (en) * 1977-06-08 1984-03-07 Merck & Co Inc Somatostatin analogs,process for their preparation and pharmaceutical compositions containing them
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4328214A (en) * 1979-07-04 1982-05-04 Ciba-Geigy Corporation Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4374060A (en) * 1981-07-15 1983-02-15 Merck & Co., Inc. Process for the preparation of cyclic hexapeptide
EP0083305B1 (de) * 1981-12-24 1985-07-10 Ciba-Geigy Ag Cyclische Octapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
US4522813A (en) * 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
NL8503426A (nl) * 1984-12-24 1986-07-16 Sandoz Ag 8alfa-acylamino-ergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
HU198626B (en) * 1986-05-27 1989-11-28 Sandoz Ag Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
AU639371B2 (en) * 1987-07-10 1993-07-22 Novartis Ag Method of treating breast cancer
US5187150A (en) * 1987-10-14 1993-02-16 Debiopharm S.A. Polyester-based composition for the controlled release of polypeptide medicinal substances
AU2284588A (en) * 1988-09-26 1990-03-29 Sandoz Ltd. Improvements in or relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体

Also Published As

Publication number Publication date
GR880100458A (en) 1989-04-12
DE3822557A1 (de) 1989-01-19
PT87957B (pt) 1995-03-01
IE882091L (en) 1989-01-10
GR1000172B (el) 1991-11-15
DK385488A (da) 1989-01-11
LU87268A1 (fr) 1989-03-08
MY109309A (en) 1997-01-31
FI93308B (sv) 1994-12-15
HUT47865A (en) 1989-04-28
AU618270B2 (en) 1991-12-19
CY1631A (en) 1992-07-10
NL194823C (nl) 2003-04-03
US6066616A (en) 2000-05-23
JP2764041B2 (ja) 1998-06-11
DE3822557C2 (de) 1998-07-02
NO883054L (no) 1989-01-11
FR2617714B1 (fr) 1991-09-20
NO883054D0 (no) 1988-07-08
SG3692G (en) 1992-03-20
CH677449A5 (sv) 1991-05-31
SE9301290A0 (sv) 1993-04-20
DK200100558A (da) 2001-04-04
MY103746A (en) 1993-09-30
JP2578477B2 (ja) 1997-02-05
JPH0748272A (ja) 1995-02-21
US5753618A (en) 1998-05-19
CS411591A3 (en) 1992-06-17
NL194823B (nl) 2002-12-02
IE61908B1 (en) 1994-11-30
SE8802569D0 (sv) 1988-07-08
FI883261A (sv) 1989-01-11
JPS6431728A (en) 1989-02-02
AU1889388A (en) 1989-01-12
BE1001079A4 (fr) 1989-07-04
HU203480B (en) 1991-08-28
HK16492A (en) 1992-03-06
DK174476B1 (da) 2003-04-14
FI93308C (sv) 1995-03-27
CY1632A (en) 1992-07-10
ES2010561A6 (es) 1989-11-16
IL87044A0 (en) 1988-12-30
CA1328402C (en) 1994-04-12
SE503191C2 (sv) 1996-04-15
FI883261A0 (sv) 1988-07-08
DK174125B1 (da) 2002-07-01
DK385488D0 (da) 1988-07-08
PT87957A (pt) 1989-06-30
GB2208200B (en) 1991-11-27
SE8802569L (sv) 1989-01-11
NO179359C (no) 1996-09-25
NZ225340A (en) 1991-05-28
NL8801734A (nl) 1989-02-01
DE3845000C2 (de) 1998-11-19
GB2208200A (en) 1989-03-15
FR2617714A1 (fr) 1989-01-13
NO179359B (no) 1996-06-17
GB8816024D0 (en) 1988-08-10

Similar Documents

Publication Publication Date Title
SE9301290D0 (sv) Anvaendning av en somatostatinanalog
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ES2055911T3 (es) Compuesto farmaceutico adelgazante.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
IL102848A0 (en) Polypeptides having growth hormone releasing activity,their use and pharmaceutical compositions containing them
ATE66614T1 (de) Insulinzubereitung fuer nicht-parenterale verabreichung.
UA26855C2 (uk) Фармацевтичhа композиція, яка регулює гематопоез
DE69003392D1 (de) Dosisform zur oralen verabreichung des hypoglykämischen glipizids.
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
DK420385D0 (da) Antioestrogent laegemiddel til perkutan indgift
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
ATE74006T1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
DE3650358D1 (de) Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
GB1395090A (en) Stabilized hormone compositions
PH27446A (en) Compound with gastric acid inhibitory effect
BR8008818A (pt) Peptidos farmacologicamente ativos e medicamentos contendo os mesmos
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
DE59108104D1 (de) Arzneimittel enthaltend cd14
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
AU5198686A (en) Praparat zur intramuskularen injektion von medikamenten vitaminen oder impfstoffen
GB1507643A (en) 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis
DE3686536D1 (de) Oxytocin und antigestagen zur einleitung der geburt.
GB1330993A (en) Mixture of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinsons disease

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9301290-4